Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy

Archives of Ophthalmology

Volumn 114, Issue 11, 1996, Pages 1321-1328

  Gallie, Brenda L ^a,d   Budning, Andrew ^a   DeBoer, Gerrit ^a,e   Thiessen, Jake J ^b   Koren, Gideon ^b,c   Verjee, Zul ^c   Ling, Victor ^f   Chan, Helen S L ^b,c,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^e DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CYCLOSPORIN; TENIPOSIDE; VINCRISTINE;

ARTICLE; BEAM THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; HUMAN; PRIORITY JOURNAL; RETINOBLASTOMA; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0029975775     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.1996.01100140521001     Document Type: Article

References (35)

1. Abramson DH, Ellsworth RM, Tretter P, Adams K, Kitchin FD. Simultaneous bilateral radiation for advanced bilateral retinoblastoma. Arch Ophthalmol. 1981; 99:1763-1766.
2. Shields JA, Parsons H, Shields CL, Giblin ME. The role of cryotherapy in the management of retinoblastoma. Am J Ophthalmol. 1989;108:260-264.
3. Abramson DH. The focal treatment of retinoblastoma with emphasis on xenon arc photocoagulation. Acta Ophthalmol Scand Suppl. 1989;194:3-63.
4. Eng C, Li FP, Abramson DH, et al. Mortality from second tumors among long-term survivors of retinoblastoma. J Natl Cancer Inst. 1993;85:1121-1128.
5. Imhof SM, Hofman P, Tan KE. Quantification of lacrimal function after D-shaped field irradiation for retinoblastoma. Br J Ophthalmol. 1993;77:482-484.
6. Zelter M, Gonzalez G, Schwartz L, et al. Treatment of retinoblastoma: results obtained from a prospective study of 51 patients. Cancer. 1988;61: 153-160.
7. White L. Chemotherapy in retinoblastoma: current status and future directions. Am J Pediatr Hematol Oncol. 1991;13:189-201.
8. Chan HSL, Canton MD, Gallie BL. Chemosensitivity and multidrug resistance to antineoplastic drugs in retinoblastoma cell lines. Anticancer Res. 1989;9:469-474.
9. Chan HSL, Thorner PS, Haddad G, Gallie BL. Multidrug-resistant phenotype in retinoblastoma correlates with P-glycoprotein expression. Ophthalmology. 1991; 98;1425-1431.
10. Chan HSL, Thorner PS, Haddad G, Ling V. Immunohistochemical detection of P-glycoprotein: prognostic correlation in soft tissue sarcoma of childhood. J Clin Oncol. 1990;8:689-704.
11. Chan HSL, Haddad G, Thorner PS, et al. P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma. N Engl J Med. 1991;325: 1608-1614.
12. Chan HSL, Haddad G, Thorner PS, DeBoer G, Ling V. Multidrug resistance in childhood malignancies. In: Fortner JG, Rhoads JE, eds. Accomplishments in Cancer Research 1991, General Motors Cancer Research Foundation. Philadelphia, Pa: JB Lippincott; 1992:184-216.
13. Gerlach JH, Endicott JA, Juranka PF, et al. Homology between P-glycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug resistance. Nature. 1986;324:485-489.
14. Lee TW, Yang SW, Kim CM, Hong WS, Youn DH. Chemosensitization to adriamycin by Cyclosporin A and verapamil in human retinoblastoma cell lines. J Korean Med Sci. 1993;8:104-109.
15. Georges E, Sharom FJ, Ling V. Multidrug resistance and Chemosensitization: therapeutic implications for cancer chemotherapy. In: August T, Anders MW, Murad F, Nies A, eds. Advances in Pharmacology. San Diego, Calif: Academic Press Inc; 1990:185-220.
16. Augsburger JJ, Faulkner CB. Indirect ophthalmoscope argon laser treatment of retinoblastoma. Ophthalmic Surg. 1992;23:591-593.
17. Chan HSL, DeBoer G, Thiessen JJ, et al. Combining cyclosporine with chemotherapy controls intraocular retinoblastoma without radiation. Clin Cancer Res. 1996;2:1499-1508.
18. Rozencweig M, Stagnet M, Hansen HH, et al. EORTC guidelines for phase I trials with single agents in adults: EORTC New Drug Development Committee, Eur J Cancer Clin Oncol. 1985;21:1005-1007.
19. Ellsworth RM. The practical management of retinoblastoma. Trans Am Ophthalmol Soc. 1969;67:462-534.
20. Bedford MA, Bedotto C, Macfaul PA. Retinoblastoma: a study of 139 cases. Br J Ophthalmol. 1971;55:19-27.
21. Shields JA, Shields CL, De Potter P. Cryotherapy for retinoblastoma. Int Ophthalmol Clin. 1993;33:101-105.
22. Hryniuk WM. The importance of dose intensity in the outcome of chemotherapy. Important Adv Oncol. 1988;121-141.
23. Longo DL, Duffey PL, DeVita Jr VT, Wesley MN, Hubbard SM, Young RC. The calculation of actual or received dose intensity: a comparison of published methods. J Clin Oncol. 1991;9:2042-2051.
24. Schipper J, Tan KE, Van Peperzeel HA. Treatment of retinoblastoma by precision megavoltage radiation therapy. Radiother Oncol. 1985;3:117-132.
25. Phillips RA, Gill RM, Zacksenhaus E, et al. Why don't germline mutations in RB1 predispose to leukemia? Curr Top Microbiol Immunol. 1992;182:485-491.
26. Pui CH, Ribeiro RC, Hancock ML, et al. Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. N Engl J Med. 1991;325:1682-1687.
27. Chan HSL, Thomer PS, Haddad G, Gallie BL. Effect of chemotherapy on intraocular retinoblastoma. Int J Pediatr Hematol Oncol. 1995;2:269-281.
28. Scanlon KJ, Wang WZ, Man H. Cyclosporin A suppresses cisplatin-induced oncogene expression in human cancer cells. Cancer Treat Rev. 1990;17(suppl A):27-35.
29. Morgan Jr RJ, Margolin K, Raschko J, et al. Phase I trial of carboplatin and infusional cyclosporine in advanced malignancy. J Clin Oncol. 1995;13:2238-2246.
30. Sato JK, Gomer C, Murphree L. Carboplatin and laser hyperthermia: a novel and effective therapy for intraocular retinoblastoma. Proc Am Assoc Cancer Res. 1993;34:A1172. Abstract.
31. Fisher AM, Murphree AL, Gomer CJ. Clinical and preclinical photodynamic therapy. Lasers Surg Med. 1995;17:2-31.
32. Cole SPC, Bhardwaj G, Gerlach JH, et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science. 1992;258:1650-1654.
33. Beck WT. Unknotting the complexities of multidrug resistance: the involvement of DNA topoisomerases in drug action and resistance. J Natl Cancer Inst. 1989;81:1683-1685.
34. Tew KD. Glutathione-associated enzymes in anticancer drug resistance. Cancer Res. 1994;54:4313-4320.
35. Scheper RJ, Broxterman HJ, Scheffer GL, et al. Overexpression of a M(r) 110 000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. Cancer Res. 1993;53:1475-1479.